A basic tool to determine exercise capacity in
COPD: 4-meter gait speed

karcıoğlu, oğuz; SARINC ULASLI, SEVINC; demir, ahmet

doi:10.5578/tt.20229907

A basic tool to determine exercise capacity in COPD: 4-meter gait speed

Oğuz KARCIOĞLU, (Hacettepe Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Ankara, Türkiye)

Sevinc SARİNC ULASLİ, (Hacettepe Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Ankara, Türkiye)

Ahmet Uğur DEMİR (Hacettepe Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Ankara, Türkiye)

Tüberküloz ve Toraks

1 0

Yıl: 2022 Cilt: 70 Sayı: 1 Sayfa Aralığı: 54 - 62 Metin Dili: İngilizce DOI: 10.5578/tt.20229907 İndeks Tarihi: 29-06-2022

A basic tool to determine exercise capacity in COPD: 4-meter gait speed

Öz:

Introduction: Determination of exercise capacity is crucial for chronic obstructive pulmonary disease (COPD) management since it is an indicator of life quality and mortality. Various previously defined tests, including the cardiopulmonary exercise test (CPET), the 6-minute walking test (6MWT), and the incremental shuttle walk test, are used to determine COPD patients’ exercise capacity. However, they all have some disadvantages, such as time, personnel, and equipment requirements, limiting their daily practice use. Here, it was aimed to investigate the role of 4-meter gait speed (4mGS) in evaluating exercise capacity in COPD. Materials and Methods: We included 40-to-70-year-old COPD patients with no contraindications for exercise testing. We performed the tests at standard intervals without affecting each other’s results. We also performed spirometry. We used the modified Medical Research Council Scale, COPD Assessment Test, and BODE index to determine the current status of individuals. Results: Twenty-three (female/male= 2/21) subjects aged 58.1 ± 7.3 were included in the study. A statistically significant correlation was observed between 4mGS and peak VO2 values. There was also a statistically significant relationship between 4mGS and 6MWT distance. 4mGS correlated with CAT and BODE scores to represent the general medical status of patients. Conclusion: Considering its easy applicability and reproducibility, 4mGS seems to be a strong candidate for daily clinical use in monitoring the exercise capacity of COPD patients. Further studies in larger patient groups are needed to support these results.

Anahtar Kelime:

KOAH’ta egzersiz kapasitesinin belirlenmesinde basit bir test: 4 metre yürüme hızı

Öz:

Giriş: Egzersiz kapasitesinin belirlenmesi, yaşam kalitesi ve mortalitenin bir göstergesi olması nedeniyle kronik obstrüktif akciğer hastalığı (KOAH) yönetimi için çok önemlidir. Kronik obstrüktif akciğer hastalarının egzersiz kapasitesini belirlemek için kardiyopulmoner egzersiz testi (KPET), 6 dakikalık yürüme testi (6DYT) ve artımlı mekik yürüme testi dahil olmak üzere önceden tanımlanmış çeşitli testler kullanılır. Ancak hepsinin zaman, personel ve ekipman gereksinimleri gibi günlük pratik kullanımlarını sınırlayan bazı dezavantajları vardır. Bu çalışmada KOAH'ta egzersiz kapasitesini değerlendirmede 4 metrelik yürüme hızının (4mYH) rolünü araştırmayı amaçladık. Materyal ve Metod: Egzersiz testi için kontrendikasyonu olmayan 40-70 yaşındaki KOAH hastaları çalışmaya dahil edildi. Testler birbirinin sonuçlarını etkilemeyecek şekilde standart aralıklarla gerçekleştirildi. Ayrıca her hastaya spirometri yapıldı. Bireylerin mevcut durumunu belirlemek için değiştirilmiş modifed Medical Research Council dispne ölçeği, KOAH Değerlendirme Testi ve BODE endeksi kullanıldı. Bulgular: Yaşları 58.1 ± 7.3 olan 23 (kadın/erkek: 2/21) hasta çalışmaya dahil edildi. 4mYH ile tepe VO2 değerleri arasında istatistiksel olarak anlamlı bir korelasyon gözlendi. 4mYH ve 6DYT mesafesi arasında da istatistiksel olarak anlamlı bir ilişki vardı. 4mYH ile CAT ve BODE puanları arasında anlamlı korelasyon saptandı. Sonuç: Kolay uygulanabilirliği ve tekrarlanabilirliği göz önüne alındığında, 4mYH, KOAH hastalarının egzersiz kapasitesinin izlenmesinde günlük klinik kullanım için güçlü bir aday gibi görünmektedir. Bu sonuçları desteklemek için daha büyük hasta gruplarında daha fazla çalışmaya ihtiyaç vardır.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2011 Report) 2011; 20-34.
2. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Eng J Med 2004; 350(10): 1005-12. https://doi.org/10.1056/ NEJMoa021322
3. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167(4): 544-9. https://doi.org/10.1164/rccm.200206-583OC
4. Waschki B, Kirsten A, Holz O, Müller KC, Meyer T, Watz H, et al. Physical activity is the strongest predictor of allcause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140(2): 331-42. https://doi. org/10.1378/chest.10-2521
5. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. European Respiratory Journal. 2009; 33(2): 262-72. https://doi. org/10.1183/09031936.00024608
6. Nelson N, Asplund CA. Exercise testing: who, when, and why? PM&R 2016; 8(3): S16-S23. https://doi. org/10.1016/j.pmrj.2015.10.019
7. Palange P, Ward S, Carlsen K, Casaburi R, Gallagher C, Gosselink R, et al. Recommendations on the use of exercise testing in clinical practice. Eur Resp J 2007; 29(1): 185-209. https://doi.org/10.1183/09031936.00046906
8. Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto Plata V, Vestbo J, et al. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Resp Crit Care Med 2013; 187(4): 382-6. https://doi.org/10.1164/ rccm.201209-1596OC
9. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Resp J 2014; 44(6): 1428- 46. https://doi.org/10.1183/09031936.00150314
10. Singh SJ, Jones P, Evans R, Morgan M. Minimum clinically important improvement for the incremental shuttle walking test. Thorax 2008; 63(9): 775-7. https://doi. org/10.1136/thx.2007.081208
11. Mehmet H, Robinson SR, Yang AWH. Assessment of gait speed in older adults. J Geriatr Phys Ther 2020; 43(1): 42-52. https://doi.org/10.1519/JPT.0000000000000224
12. Van Kan GA, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009; 13(10): 881-9. https://doi.org/10.1007/s12603-009-0246-z
13. Kon SS, Patel MS, Canavan JL, Clark AL, Jones SE, Nolan CM, et al. Reliability and validity of 4-metre gait speed in COPD. Eur Resp J 2013; 42(2): 333-40. https://doi. org/10.1183/09031936.00162712
14. Karpman C, Benzo R. Gait speed as a measure of functional status in COPD patients. Int J Chron Obstruct Pulmon Dis 2014; 9: 1315. https://doi.org/10.2147/ COPD.S54481
15. Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-7. https://doi.org/10.1164/ajrccm.166.1.at1102
16. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Resp J 2005; 26(2): 319-38. https://doi.org/10.1183/09031936 .05.00034805
17. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010; 122(2): 191-225. https://doi.org/10.1161/CIR.0b013e3181e52e69
18. Ewert R, Obst A, Mühle A, Halank M, Winkler J, Trümper B, et al. Value of Cardiopulmonary Exercise Testing in the Prognosis Assessment of Chronic Obstructive Pulmonary Disease Patients: A Retrospective, Multicentre Cohort Study. Respiration 2021; 19: 1-14. https://doi. org/10.1159/000519750
19. Çalış İ. A comparison of cardiopulmonary exercise test and 6 minute walking test in determination of exercise capacity in chronic obstructive pulmonary disease. Tuberk Toraks 2014; 62(4): 259-66. https://doi.org/10.5578/ tt.8516
20. Oudiz RJ, Barst RJ, Hansen JE, Sun XG, Garofano R, Wu X, et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006; 97(1): 123-6. https://doi.org/10.1016/j. amjcard.2005.07.129
21. Karpman C, DePew ZS, LeBrasseur NK, Novotny PJ, Benzo RP. Determinants of gait speed in COPD. Chest 2014; 146(1): 104-10. https://doi.org/10.1378/chest.13-2017
22. DePew ZS, Karpman C, Novotny PJ, Benzo RP. Correlations between gait speed, 6-minute walk distance, physical activity, and self-efficacy in patients with severe chronic lung disease. Resp Care 2013; 58(12): 2113-9. https:// doi.org/10.4187/respcare.02471
23. Araya S, Wordofa M, Mamo MA, Tsegay YG, Hordofa A, Negesso AE, et al. The magnitude of hematological abnormalities among COVID-19 patients in Addis Ababa, Ethiopia. J Multidiscip Healthc 2021; 14: 545. https://doi. org/10.2147/JMDH.S295432
24. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121(5): 1434-40. https://doi.org/10.1378/chest.121.5.1434
25. Feliz Rodriguez D, Zudaire S, Carpio C, Martínez E, Gómez-Mendieta A, Santiago A, et al. Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value. Canad Resp J 2013; 20(5): e92-e7. https:// doi.org/10.1155/2013/398120
26. Bernabeu-Mora R, Giménez Giménez LM, Montilla Herrador J, García Guillamón G, García Vidal JA, Medina Mirapeix F. Determinants of each domain of the Short Physical Performance Battery in COPD. Int J Chro Obstr Pulm Dis 2017; 12: 2539. https://doi.org/10.2147/ COPD.S138402
27. Nakano T, Kimura S, Yamashita T, Yoshimi M, Tao Y, Takata S. Correlation of 4-meter gait speed with clinical indicators of chronic obstructive pulmonary disease. Resp Investig 2021; 59(4): 505-12. https://doi.org/10.1016/j.resinv. 2021.03.008
28. Ostir GV, Berges I, Kuo Y-F, Goodwin JS, Ottenbacher KJ, Guralnik JM. Assessing gait speed in acutely ill older patients admitted to an acute care for elders hospital unit. Arch Int Med 2012; 172(4): 353-8. https://doi. org/10.1001/archinternmed.2011.1615
29. Karege G, Zekry D, Allali G, Adler D, Marti C. Gait speed is associated with death or readmission among patients surviving acute hypercapnic respiratory failure. BMJ Open Resp Res 2020; 7(1): e000542. https://doi.org/10.1136/ bmjresp-2019-000542
30. Walsh JA, Barker RE, Kon SS, Jones SE, Banya W, Nolan CM, et al. Gait speed and adverse outcomes following hospitalised exacerbation of COPD. Eur Resp J 2021; 58(5): 2004047. https://doi.org/10.1183/13993003.04047-2020

APA	karcıoğlu o, SARINC ULASLI S, demir a (2022). A basic tool to determine exercise capacity in COPD: 4-meter gait speed. , 54 - 62. 10.5578/tt.20229907
Chicago	karcıoğlu oğuz,SARINC ULASLI SEVINC,demir ahmet A basic tool to determine exercise capacity in COPD: 4-meter gait speed. (2022): 54 - 62. 10.5578/tt.20229907
MLA	karcıoğlu oğuz,SARINC ULASLI SEVINC,demir ahmet A basic tool to determine exercise capacity in COPD: 4-meter gait speed. , 2022, ss.54 - 62. 10.5578/tt.20229907
AMA	karcıoğlu o,SARINC ULASLI S,demir a A basic tool to determine exercise capacity in COPD: 4-meter gait speed. . 2022; 54 - 62. 10.5578/tt.20229907
Vancouver	karcıoğlu o,SARINC ULASLI S,demir a A basic tool to determine exercise capacity in COPD: 4-meter gait speed. . 2022; 54 - 62. 10.5578/tt.20229907
IEEE	karcıoğlu o,SARINC ULASLI S,demir a "A basic tool to determine exercise capacity in COPD: 4-meter gait speed." , ss.54 - 62, 2022. 10.5578/tt.20229907
ISNAD	karcıoğlu, oğuz vd. "A basic tool to determine exercise capacity in COPD: 4-meter gait speed". (2022), 54-62. https://doi.org/10.5578/tt.20229907

APA	karcıoğlu o, SARINC ULASLI S, demir a (2022). A basic tool to determine exercise capacity in COPD: 4-meter gait speed. Tüberküloz ve Toraks, 70(1), 54 - 62. 10.5578/tt.20229907
Chicago	karcıoğlu oğuz,SARINC ULASLI SEVINC,demir ahmet A basic tool to determine exercise capacity in COPD: 4-meter gait speed. Tüberküloz ve Toraks 70, no.1 (2022): 54 - 62. 10.5578/tt.20229907
MLA	karcıoğlu oğuz,SARINC ULASLI SEVINC,demir ahmet A basic tool to determine exercise capacity in COPD: 4-meter gait speed. Tüberküloz ve Toraks, vol.70, no.1, 2022, ss.54 - 62. 10.5578/tt.20229907
AMA	karcıoğlu o,SARINC ULASLI S,demir a A basic tool to determine exercise capacity in COPD: 4-meter gait speed. Tüberküloz ve Toraks. 2022; 70(1): 54 - 62. 10.5578/tt.20229907
Vancouver	karcıoğlu o,SARINC ULASLI S,demir a A basic tool to determine exercise capacity in COPD: 4-meter gait speed. Tüberküloz ve Toraks. 2022; 70(1): 54 - 62. 10.5578/tt.20229907
IEEE	karcıoğlu o,SARINC ULASLI S,demir a "A basic tool to determine exercise capacity in COPD: 4-meter gait speed." Tüberküloz ve Toraks, 70, ss.54 - 62, 2022. 10.5578/tt.20229907
ISNAD	karcıoğlu, oğuz vd. "A basic tool to determine exercise capacity in COPD: 4-meter gait speed". Tüberküloz ve Toraks 70/1 (2022), 54-62. https://doi.org/10.5578/tt.20229907